Related Experiment Video
Updated: Apr 18, 2026
09:29
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
12.1K
Immunity unmasks APOL1 in collapsing glomerulopathy
Bairbre A McNicholas1, Peter J Nelson1
1Division of Nephrology and Kidney Research Institute, University of Washington, Seattle, Washington, USA.
Kidney International
|January 31, 2015
Summary
Collapsing glomerulopathy disproportionately affects people of African ancestry. A new study suggests ongoing immune responses may trigger harmful APOL1 gene variants in kidney podocytes, explaining disease development.
Area of Science:
- Nephrology
- Genetics
- Immunology
Background:
- Collapsing glomerulopathy is a severe kidney disease primarily affecting individuals of African ancestry.
- Onset often coincides with a period of heightened immune system activity due to other conditions.
Purpose of the Study:
- To investigate the mechanism linking immune responses to collapsing glomerulopathy in at-risk populations.
- To identify the role of APOL1 gene variants in disease pathogenesis.
Main Methods:
- The study by Nichols et al. examined the interaction between immune system activation and APOL1 allelic variants.
- Focus was placed on the impact on podocytes, critical kidney filtering cells.
Main Results:
- Evidence suggests that immune responses can indirectly induce pathogenic APOL1 variants in podocytes.
- This collateral induction provides a potential explanation for collapsing glomerulopathy.
Conclusions:
- The findings propose a novel pathway for collapsing glomerulopathy development.
- Targeting immune-mediated APOL1 variant induction may offer therapeutic strategies for affected individuals.
